CD4 and COVID-19: For this, we tested plasma from 37 COVID-19 samples with (n = 16) or without (n = 21) IgM ALAb, five HD, and two flu-infected individuals for their ability to induce CDC of HD CD4+, CD8+, or B lymphocytes.